跳转至内容
Merck
CN

93304

Trizma ®

≥99.0% (T)

别名:

2-氨基-2-(羟甲基)-1,3-丙二醇, THAM, Tris 碱, 三羟甲基氨基甲烷, 氨基丁三醇

登录 查看组织和合同定价。

选择尺寸


关于此项目

线性分子式:
NH2C(CH2OH)3
化学文摘社编号:
分子量:
121.14
EC Number:
201-064-4
UNSPSC Code:
12161700
MDL number:
Beilstein/REAXYS Number:
741883
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

description

aminopeptidase substrate

assay

≥99.0% (T)

form

crystalline

loss

≤1% loss on drying, 110 °C

color

white to very faintly yellow

useful pH range

7-9

pKa (25 °C)

8.1

bp

219-220 °C/10 mmHg (lit.)

mp

167-172 °C (lit.)

solubility

H2O: 1 M at 20 °C, clear

SMILES string

NC(CO)(CO)CO

InChI

1S/C4H11NO3/c5-4(1-6,2-7)3-8/h6-8H,1-3,5H2

InChI key

LENZDBCJOHFCAS-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

Other Notes

所有缓冲液的 pH 值都取决于温度和浓度。Tris 缓冲液,温度每降低 1°C,pH 值增加约 0.03 个单位,每稀释十倍 pH 值降低0.03-0.05 个单位。
对于精确的应用,使用经过精心校准的 pH 计和玻璃/甘汞组合电极。

Legal Information

Trizma is a registered trademark of Merck KGaA, Darmstadt, Germany

法规信息

新产品

此项目有


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Sean Ekins et al.
Drug metabolism and disposition: the biological fate of chemicals, 38(12), 2302-2308 (2010-09-17)
Drug-induced liver injury (DILI) is one of the most important reasons for drug development failure at both preapproval and postapproval stages. There has been increased interest in developing predictive in vivo, in vitro, and in silico models to identify compounds
Nigel Greene et al.
Chemical research in toxicology, 23(7), 1215-1222 (2010-06-18)
Drug-induced liver injury is a major issue of concern and has led to the withdrawal of a significant number of marketed drugs. An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential
Zhichao Liu et al.
PLoS computational biology, 7(12), e1002310-e1002310 (2011-12-24)
Drug-induced liver injury (DILI) is a significant concern in drug development due to the poor concordance between preclinical and clinical findings of liver toxicity. We hypothesized that the DILI types (hepatotoxic side effects) seen in the clinic can be translated

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持